← Open Payments lookup

GARY ALEXANDER: Open Payments

NPI 1811967797 · GRIFFIN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$491 in 26 payments from 15 companies in 2025. Trend: 2023 $458 · 2024 $310 · 2025 $491

Food & beverage: $491
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP4$90
ABBVIE INC.3$59
Sumitomo Pharma America, Inc.3$50
PFIZER INC.3$49
Novo Nordisk Inc2$41
GlaxoSmithKline, LLC.2$40
Noven Therapeutics, LLC1$25
Boehringer Ingelheim Pharmaceuticals, Inc.1$20
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$19
Amgen Inc.1$18

Products named: AIRSUPRA, GEMTESA, ELIQUIS, QULIPTA, Xelstrym, Ozempic, SHINGRIX, Wegovy.

Industry payments across GA — which companies pay providers there.